The changing NHS customerAs NHS customers change, CSOs are having to adapt and forge new partnerships, and develop new skills.
Over the years, the numbers of women taking up positions of authority in the pharmaceutical industry has grown considerably, and …
A new survey of the UK pharmaceutical industry suggests the sector is failing to hire the best talent because of …
More drugs are to be switched to NICE's new fast-track appraisal system, with the government reaffirming its pledge to end …
Novartis' new treatment for the rare and difficult to treat condition of transfusional iron overload has been approved in the …
Here's a challenge: find someone with PhD-level scientific knowledge, a strong management track record and entrepreneurial flair. If there are …
GlaxoSmithKline has formed an alliance with Californian biotech company ChemoCentryx through its innovative drug development partnering unit.A licensing deal has …
The blockbuster non-Hodgkin's lymphoma treatment MabThera could offer a new treatment option for people with multiple sclerosis according to new …
Newbury and Community PCT has lost its appeal against NICE's recommendation for cancer drug Herceptin, finally ending the battle over …
The first ever awards for business intelligence and market research in the UK pharmaceutical industry have been launched to recognise …
Recently I was wandering through the local market, and found myself in front of a stall selling therapeutic magnets. I …
Pfizer's new chief executive Jeffery Kindler has unveiled changes to the company's senior management structure just days into his new …
Pfizer has enlisted PR agency Reynolds-Mackenzie to support the UK launch and subsequent development of its potential blockbuster kidney cancer …
The announcements on NHS budget deficits and the debates surrounding the prescribing of costly drugs, such as in the Herceptin …
Aromatase inhibitors are to become more widely available for post-menopausal women with early breast cancer.As expected, NICE's final appraisal determination …
UK biotech company Vernalis has started enrolment into a phase II trial of V3381, a drug designed for patients with …
A new report has revealed large differences in how NHS money is spent across England, with some PCTs spending much …
The British Medical Association is questioning the government over a possible 300 million pound drop in funding available for medical …
An NHS watchdog has urged renewed efforts to cut the number of drug errors by improving prescribing and dispensing in …
A generic company has launched a version of blood-thinning blockbuster product Plavix in the US, threatening the $3.3 billion sales …